Detalhe da pesquisa
1.
Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.
N Engl J Med
; 384(9): 795-807, 2021 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33306283
2.
Safety and pharmacokinetics of antifungal agent VT-1598 and its primary metabolite, VT-11134, in healthy adult subjects: phase 1, first-in-human, randomized, double-blind, placebo-controlled study of single-ascending oral doses of VT-1598.
Med Mycol
; 62(4)2024 Mar 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-38569652
3.
Daily fosfomycin versus levofloxacin for complicated urinary tract infections.
mBio
; 14(5): e0167723, 2023 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37698412
4.
Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trial.
Lancet Infect Dis
; 23(4): 484-495, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36525985
5.
Baricitinib Treatment of Coronavirus Disease 2019 Is Associated With a Reduction in Secondary Infections.
Open Forum Infect Dis
; 10(5): ofad205, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37206623
6.
Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case.
Open Forum Infect Dis
; 10(6): ofad290, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37383244
7.
Dalbavancin as an option for treatment of S. aureus bacteremia (DOTS): study protocol for a phase 2b, multicenter, randomized, open-label clinical trial.
Trials
; 23(1): 407, 2022 May 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35578360
8.
Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children: The SCOUT-CAP Randomized Clinical Trial.
JAMA Pediatr
; 176(3): 253-261, 2022 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35040920
9.
Staphylococcus simulans: A rare uropathogen.
IDCases
; 25: e01202, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34195001